Back to search results

Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies

Abroad (travel likely)RecruitingPHASE1

Conditions

Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Childrens National Medical Center, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Keri Toner, MD) · KToner@childrensnational.org · 202-476-7538
    Contact: Principal Investigator (Keri Toner, MD)

  • Tania Jain, MD, Baltimore, Maryland, United States

    Contact: Study coordinator (Tania Jain, MD) · tjain2@jhmi.edu
    Contact: Principal Investigator (Tania Jain, MD)
View source on ClinicalTrials.gov(opens in a new tab)